Shiji Fang | Medicine | Best Researcher Award

Published on 25/08/202625/08/2026 by Research Hypothesis

Best Researcher Award

Shiji Fang
Lishui Central Hospital, China

Shiji Fang
Affiliation	Lishui Central Hospital
Country	China
Scopus ID	57192204982
Documents	91
Citations	2,574
h-index	27
Subject Area	Medicine
Event	International Research Hypothesis Excellence Award
ORCID	0009-0004-4998-5039

Shiji Fang is a medical researcher affiliated with Lishui Central Hospital in China whose indexed research profile reflects sustained scholarly activity in biomedical and translational medicine. The available Scopus-derived profile records 91 documents, 2,574 citations and an h-index of 27, indicating a substantial body of indexed research and citation activity. [1][2]

Contents

Abstract
Keywords
Introduction
Research Profile
Research Contributions
Publications
Research Impact
Award Suitability
Conclusion
External Links
References

Abstract

Shiji Fang’s research profile is situated within medicine and includes a substantial body of indexed scholarly work. The supplied publication record highlights research at the intersection of cancer biology, tumor microenvironment, immunotherapy and nanomedicine. Recent studies address mechanisms and therapeutic approaches involving immunogenic cell death, reactive oxygen species, endoplasmic reticulum stress, cellular senescence, copper homeostasis, ferroptosis, cuproptosis, chemoembolization and MRI-guided therapeutic systems. [1] [2]

Keywords

Shiji Fang; Best Researcher Award; Medicine; cancer research; hepatocellular carcinoma; immunotherapy; nanomedicine; immunogenic cell death; ferroptosis; cuproptosis; tumor biology; therapeutic delivery; translational medicine; oxidative stress; endoplasmic reticulum stress.

Introduction

Contemporary cancer research increasingly integrates molecular oncology with materials science, immunology and targeted therapeutic delivery. Hepatocellular carcinoma in particular presents a complex therapeutic environment in which tumor heterogeneity, immune suppression and resistance mechanisms can limit treatment effectiveness. Research that investigates interactions among tumor cells, immune pathways and therapeutic nanoplatforms therefore forms an important component of translational biomedical investigation.[2] [3]

Research Profile

The supplied Scopus profile identifies Shiji Fang with Author ID 57192204982 and lists Lishui Central Hospital, China, as the institutional affiliation. The profile is associated with the subject area of Medicine and records 91 indexed documents, 2,574 citations and an h-index of 27. [1]

Research characteristics

Primary discipline: Medicine.
Institutional affiliation: Lishui Central Hospital, China.
Scopus Author ID: 57192204982.
Indexed documents: 91.
Reported citations: 2,574.
Reported h-index: 27.
Major themes represented: cancer biology, hepatocellular carcinoma, immunotherapy, nanomedicine and regulated cell-death mechanisms.

Research Contributions

The supplied publications indicate several connected areas of research contribution. One strand examines how natural or bioactive compounds can influence cancer-cell death and stress-response pathways. The 2025 article on astragalin investigates immunogenic cell death in liver cancer in connection with NQO2, reactive oxygen species and endoplasmic reticulum stress. [2]

A second strand concerns the integration of cellular senescence with immune activation. The study published in Advanced Science describes a biomimetic nanomedicine approach designed around senescence-modulated immune activation and its potential relationship with immunotherapy efficacy in hepatocellular carcinoma. [3]

Publications

The following selected publications are taken from the supplied Scopus-derived research information. The list emphasizes recent 2025 articles and includes DOI identifiers where provided.

Astragalin induces immunogenic cell death in liver cancer by targeting NQO2 to promote ROS-mediated endoplasmic reticulum stress pathway. Free Radical Biology and Medicine.
Biomimetic Nanomedicine for Senescence-Modulated Immune Activation Enhances Immunotherapy Efficacy in Hepatocellular Carcinoma. Advanced Science.
Cascade-targeting copper homeostasis nano-regulators for mild-photothermal boosted cuproptosis/ferroptosis mediated breast cancer therapy. Journal of Nanobiotechnology.
Corrigendum to “Fangchinoline inhibits metastasis and reduces inflammation-induced epithelial-mesenchymal transition by targeting the FOXM1-ADAM17 axis in hepatocellular carcinoma”. Cellular Signalling.

Research Impact

The supplied bibliometric indicators provide a quantitative view of the visibility of the research record. With 2,574 reported citations and an h-index of 27 across 91 indexed documents, the profile demonstrates sustained citation activity within the indexed scholarly literature. [1] Bibliometric measures should nevertheless be interpreted alongside publication quality, methodological rigor, authorship contributions and the substantive influence of individual studies.

Award Suitability

The Best Researcher Award within the International Research Hypothesis Excellence Award framework can be assessed using evidence concerning research productivity, scholarly visibility, thematic contribution and relevance to the broader research community. The supplied profile provides several measurable indicators, including 91 indexed documents, 2,574 citations and an h-index of 27. [1]

Conclusion

Shiji Fang’s supplied academic profile presents an established research record in Medicine, with affiliation to Lishui Central Hospital in China and a Scopus Author ID of 57192204982. The reported 91 documents, 2,574 citations and h-index of 27 provide quantitative indicators of scholarly activity and citation visibility. [1]

External Links

References

Elsevier. (n.d.). Scopus author details: Shiji Fang, Author ID 57192204982. Scopus.
https://www.scopus.com/pages/authors/57192204982
Zheng, L., Zhao, Z., Chen, L., Yang, W., Ercolani, G., Qin, P., Lin, B., Han, M., Weng, Q., Zhang, Y., et al. (2025). Astragalin induces immunogenic cell death in liver cancer by targeting NQO2 to promote ROS-mediated endoplasmic reticulum stress pathway. Free Radical Biology and Medicine.
https://doi.org/10.1016/j.freeradbiomed.2025.07.047
Fang, S., Zheng, L., Lin, B., Chen, J., Hou, D., Ding, Y., Han, M., Qin, P., Wang, M., Guo, X., et al. (2025). Biomimetic Nanomedicine for Senescence-Modulated Immune Activation Enhances Immunotherapy Efficacy in Hepatocellular Carcinoma. Advanced Science.
https://doi.org/10.1002/advs.202517792
Liang, X., Fang, S., Xin, Y., Lei, J., Wang, W., Wei, Y., Li, W., Li, C., Tang, H., Wei, X., et al. (2025). Cascade-targeting copper homeostasis nano-regulators for mild-photothermal boosted cuproptosis/ferroptosis mediated breast cancer therapy. Journal of Nanobiotechnology.
https://doi.org/10.1186/s12951-025-03722-2
Chen, M., Chen, Y., Chen, W., Chen, X., Guo, X., Yu, J., Guo, X., Wang, M., Zhang, X., Hu, Q., et al. (2025). Immune-activated microspheres for enhanced chemoembolization of hepatocellular carcinoma by blocking the adenosine A2A receptor. Acta Biomaterialia.
https://doi.org/10.1016/j.actbio.2025.04.042
Chen, X., Zhang, F., Lu, C., Wu, R., Yang, et al. (2025). Lactate-Fueled Theranostic Nanoplatforms for Enhanced MRI-Guided Ferroptosis Synergistic with Immunotherapy of Hepatocellular Carcinoma. ACS Applied Materials and Interfaces.
https://doi.org/10.1021/acsami.4c21890

Albina Tummolo | Medicine and Health Sciences | Best Researcher Award

Published on 26/05/202526/05/2025 by Research Hypothesis

Dr. Albina Tummolo | Medicine and Health Sciences | Best Researcher Award

Albina Tummolo at Children Hospital Giovanni XXIII, Italy.

Dr. Albina Tummolo is an accomplished pediatrician specializing in metabolic and genetic disorders. With over two decades of clinical and academic experience, she has built a significant profile in managing and researching rare pediatric diseases. Based at the Policlinico of Bari, she combines patient care with academic research, national coordination roles, and continuous engagement with international advisory boards. Dr. Tummolo is also an active educator, teaching at several Italian universities and training healthcare professionals in hereditary metabolic diseases. Her work has shaped protocols and policies for improved pediatric metabolic care in Italy.

Publication Profile

Orcid

Education

Dr. Albina Tummolo earned her Degree in Medicine and Surgery from the University of Foggia in 2002 and completed her Specialization in Pediatrics (General and Specialist) at the University of Bari in 2007. She holds multiple postgraduate certifications in specialized pediatrics, infectivity, rheumatology, and rare diseases from the University of Bari and the University of Florence. She furthered her academic credentials with an MSc in Clinical Pediatrics from University College London in 2008 and a PhD in Pediatric Sciences from the University of Bari in 2011. In 2023, she completed an MSc in Epidemiology and Biostatistics at Università Cattolica di Roma.

Experience

Dr. Tummolo currently serves as a Senior Pediatrician at the Ospedale Pediatrico “Giovanni XXIII” in Bari, within the Unit of Metabolic and Genetic Diseases, a role she has held since 2015. She has also worked as a senior pediatrician at the Azienda Ospedaliera di Padova and Presidio Ospedaliero “Perrino” dell’ASL di Brindisi. She is a registered physician with the Order of Physicians and Surgeons of Bari (License No. 5742, since September 18, 2003).

Dr. Tummolo has extensive experience leading and participating in clinical trials and observational studies focused on inborn errors of metabolism, lysosomal storage disorders, and rare genetic conditions, often acting as Principal Investigator or Scientific Coordinator. She serves as a member and secretary of national expert committees and advisory boards and contributes to shaping diagnostic and therapeutic strategies for metabolic disorders in Italy and Europe.

Research Focus

Inborn errors of metabolism and rare genetic diseases
Lysosomal storage disorders (including LAL-D, Gaucher disease, and alpha-mannosidosis)
Phenylketonuria (PKU) and organic acidurias
Neonatal screening programs
Epidemiology and real-world evidence in pediatric metabolic disorders
Nutritional and enzyme replacement therapies in pediatric populations

Author Metrics & Scientific Contributions

Principal Investigator in multiple national and international clinical trials
Scientific Member of the Telethon Undiagnosed Diseases Program (TUDP) and E-HOD
Coordinator/Advisor for over 30 expert boards and working groups, including SIMMESN
Co-author of educational and clinical monographs, including:
- “Inherited Metabolic Disorders Neonatal Screening” (2014)
- Educational booklets on MSUD, TYR, HCU, MMA/PA, GA, IVA, and PKU (2020–2022)
- Springer Healthcare Monography (2025) on velmanase alfa treatment in alpha-mannosidosis

She has contributed substantially to national consensus statements, educational masterclasses, and international forums on metabolic disease management.

Publication Top Notes

1. Exploring Partners, Parenting and Pregnancy Thinking in Late Adolescents and Young Adults with Inherited Metabolic Disorders

📅 Pediatric Reports, May 2025
🔗 DOI: 10.3390/pediatric17030056
👩‍🔬 Contributors: Albina Tummolo, Giulia Paterno, Rosa Carella, Livio Melpignano, Donatella De Giovanni
Focus: Examines reproductive health perspectives in adolescents and young adults affected by inherited metabolic disorders.

2. Growth Parameters and Prevalence of Obesity in PKU Patients and Peers: Is This the Right Comparison?

📅 Pediatric Reports, October 2024
🔗 DOI: 10.3390/pediatric16040076
👩‍🔬 Contributors: Giulia Paterno, Vito Di Tullio, Rosa Carella, Giada De Ruvo, Fabrizio Furioso, Aleksandra Skublewska-D’Elia, Donatella De Giovanni, Albina Tummolo
Focus: Investigates obesity prevalence among patients with phenylketonuria (PKU) versus healthy peers.

3. Intake Modalities of Amino Acid Supplements: A Real-World Data Collection from Phenylketonuria Patients

📅 Nutrients, February 2024
🔗 DOI: 10.3390/nu16050669
👩‍🔬 Contributors: Albina Tummolo, Rossella Carella, Pasquale Carone, Giulia Paterno, Donatella De Giovanni
Focus: Real-world insights into how PKU patients consume amino acid supplements.

4. CHAMP1-related Disorders: Pathomechanisms Triggered by Different Genomic Alterations Define Distinct Nosological Categories

📅 European Journal of Human Genetics, 2023
🔗 DOI: 10.1038/S41431-023-01305-Z
🔍 WOSUID: WOS:000939855800002
👩‍🔬 Contributors: Amenta S., Marangi G., Orteschi D., Frangella S., Gurrieri F., Paccagnella E., Scala M., Romano F., Capra V., Nigro V., et al.
Focus: Differentiates clinical categories of CHAMP1-related disorders based on genomic mechanisms.

5. Long-term Safety and Efficacy of Velmanase Alfa Treatment in Children Under 6 Years of Age with Alpha-Mannosidosis: A Phase 2, Open Label, Multicenter Study

📅 Journal of Inherited Metabolic Disease, 2023
🔗 DOI: 10.1002/JIMD.12602
🔍 WOSUID: WOS:000948401000001
👩‍🔬 Contributors: Guffon N., Konstantopoulou V., Hennermann J.B., Muschol N., Bruno I., Tummolo A., Ceravolo F., Zardi G., Ballabeni A., Lund A.
Focus: Evaluates velmanase alfa’s therapeutic profile in pediatric alpha-mannosidosis patients.

Conclusion

Dr. Albina Tummolo exemplifies the core values of the Best Researcher Award in Medicine and Health Sciences through her compassion-driven pediatric care, trailblazing research, and influence on national health systems. Her unique blend of clinical depth, academic rigor, and policy impact makes her an ideal candidate for this recognition.

She not only advances medical science but also improves the lives of children with rare diseases—one diagnosis, one protocol, and one family at a time.

Marzieh Kaboudi | Medical Hypotheses | Best Researcher Award

Published on 15/04/202515/04/2025 by Research Hypothesis

Marzieh Kaboudi | Medical Hypotheses | Best Researcher Award

Assist. Prof. Dr Marzieh Kaboudi, kums, Iran

Assist. Prof. Dr. Marzieh Kaboudi is a distinguished academician and researcher in reproductive health and midwifery with over three decades of experience in teaching, administration, and scholarly contributions. She earned her Ph.D. in Reproductive Health from Shahid Beheshti University and has held several leadership roles at the Kermanshah University of Medical Sciences. Known for her pioneering work in maternal and women’s health, she has served as Head of the Reproductive Health Department, Dean of the Nursing and Midwifery School, and an active member of research councils. Her impactful research spans maternal care, women’s reproductive behavior, and health education. She is also a respected reviewer and scientific chair in national congresses. Her ongoing dedication to advancing reproductive health science through research, teaching, and policy advocacy marks her as a highly deserving candidate for the Best Researcher Award.

Publication Profile

Google Scholar

Education

Dr. Marzieh Kaboudi’s academic journey began with a B.A. in Midwifery from Kermanshah University of Medical Sciences (1987–1991) 🎓. She pursued her M.A. in Midwifery Education at Ahvaz University of Medical Sciences (1994–1997) 📘, and later earned a Ph.D. in Reproductive Health from Shahid Beheshti University of Medical Sciences, Tehran (2008–2013) 🎓. Her educational path reflects a deep commitment to advancing women’s health and reproductive education. Her postgraduate focus on reproductive health laid the foundation for her expertise in promoting maternal dignity, pregnancy outcomes, and health behavior change. These qualifications have equipped her with the theoretical knowledge and research skills essential for effective teaching, leadership, and impactful scientific inquiry. Her academic background is complemented by specialized certifications in research methods and sexual health, enhancing her ability to lead innovative studies and mentor future healthcare professionals.

Experience

Dr. Kaboudi’s career showcases a robust record of academic and administrative excellence. She served as Head of the Reproductive Health Department at the School of Nursing and Midwifery, Kermanshah University of Medical Sciences (2017–2022) 🏥. Previously, she was Dean of the Nursing and Midwifery School (2014–2017), and Deputy Head of School (2008–2014) 📋. Earlier roles include Head of Midwifery Department (1999–2005) and Boss of the Educational Development Office (2006–2008) 🧾. She has been an influential member of the Research Council (2001–2008) and continues to serve as a referee for the university’s scientific journal 📰. Her leadership contributions span educational policy-making, research mentorship, and conference organization. Dr. Kaboudi’s experience reflects an unwavering dedication to elevating academic standards, fostering research, and improving reproductive health education. Her diverse roles demonstrate her ability to lead multidisciplinary teams and influence policy and education in healthcare.

Honors and Awards

Dr. Kaboudi’s commitment to academic excellence has earned her several prestigious accolades. She received the Outstanding Professor Prize for three consecutive years at Kermanshah University of Medical Sciences, honoring her excellence in teaching and research 🏆. She also held the Scientific Chair at national congresses such as the 2007 National Congress on Research in Education and the 2001 National Congress on Blood Health 🧠. Her academic contributions are further recognized by her ongoing role as a peer reviewer for the university’s scientific journal since 2002 📝. In addition to these honors, she has obtained specialty certifications in research methods and sexual health education, including advanced training on child sexual health and the assessment of sexual dysfunctions 📜. These achievements reflect her commitment to lifelong learning, innovative pedagogy, and reproductive health advocacy. Her awards and recognitions validate her role as a transformative leader in reproductive health research.

Research Focus

Dr. Marzieh Kaboudi’s research centers on maternal and reproductive health, health behavior change, and women’s health education. Her work investigates key issues such as neural tube defects, preeclampsia, obesity in middle-aged women, reproductive intentions, and maternal dignity 🧬. She utilizes methodologies grounded in behavioral science, including the Theory of Planned Behavior, to examine interventions that enhance reproductive outcomes 📊. Her contributions extend to health promotion, reproductive decision-making, and the development of validated tools for patient satisfaction measurement. She has also explored sexual and metabolic health, menopause knowledge, and reproductive practices among Iranian women. Through her national and international presentations, she emphasizes ethical standards, health equity, and psychosocial well-being 💬. Her research bridges the gap between clinical knowledge and public health policy, ultimately empowering women with better reproductive choices and outcomes. With an eye toward innovation and advocacy, Dr. Kaboudi’s work continues to shape the future of reproductive healthcare.

Publication Top Notes

A genome-wide association study to identify candidate genes for erectile dysfunction

A Comparison of Quality of Life, Anxiety and Depression in Children with Cancer and Healthy Children, Kermanshah-Iran

The effect of acceptance and commitment therapy on the mental health of women patients with type II diabetes

The decision-making process of childbearing: a qualitative study

The Effect of Resilience Training on the Condition of Style of Coping and Parental Stress in Mothers of Children with Leukemia

A Study of Health Literacy Components and their Relationships with Health-Promoting Behaviors in Students at Kermanshah University of Medical Sciences

The relationship between emotional intelligence and mental health with social anxiety in blind and deaf children

Investigation of gene expression and genetic simultaneous control associated with erectile dysfunction and diabetes

WEN CHANG TSENG | Medicine and Health Sciences | Best Researcher Award

Published on 13/03/202513/03/2025 by Research Hypothesis

WEN CHANG TSENG | Medicine and Health Sciences | Best Researcher Award

Mr WEN CHANG TSENG, Cathay General Hospital/Departmentof Radiology, Taiwan

Mr. Wen Chang Tseng is an accomplished medical radiologic technologist and deputy director with extensive expertise in diagnostic radiology and clinical trials. 📡🔬 With a career spanning over two decades (since 1999), he has contributed significantly to medical imaging and radiology, playing a key role in multinational clinical trials on ankylosing spondylitis and rheumatoid arthritis. 🏥 His work in advancing radiological technology has made a substantial impact in medical research, ensuring high standards in diagnostic procedures. 🎯 His dedication to improving patient care through innovative imaging techniques and clinical studies has earned him recognition as a leading expert in his field. 🌍 His contributions to Phase II and Phase III multinational studies highlight his commitment to advancing diagnostic radiology. 📈 His leadership in technology development, combined with his research experience, makes him a deserving recipient of the Best Researcher Award. 🏅👏

Publication Profile

Scopus

Education

Mr. Wen Chang Tseng holds a strong educational background in medical imaging and engineering. 🏛️ He earned his degree from the Department of Medical Imaging and Radiological Technology at Yuanpei University, where he gained in-depth knowledge of radiological sciences and medical imaging techniques. 🏥🔍 Expanding his technical expertise, he further pursued studies in the Department of Electrical Engineering at Chung Yuan Christian University, enhancing his understanding of technological applications in medical diagnostics. ⚡🖥️ His combined knowledge of radiology and electrical engineering allows him to develop and implement cutting-edge imaging solutions for enhanced patient diagnosis and treatment. 🏆 His education has provided a robust foundation for his career in medical radiology, clinical trials, and diagnostic imaging research. 🎯 His multidisciplinary academic training continues to support his innovative contributions to medical technology and radiology advancements. 📡🩻

Experience

With over two decades of experience in the field of diagnostic radiology, Mr. Wen Chang Tseng has been a cornerstone of medical imaging and radiologic technology. 🏆 Since 1999, he has been actively involved in the Diagnostic Radiology Department, applying his expertise in radiological imaging to enhance diagnostic accuracy. 🏥 His dedication and leadership have led him to serve as a Medical Radiologic Technologist and Deputy Director of Technology, where he has played a pivotal role in managing radiological procedures, research coordination, and advanced imaging technologies. 🔬🖥️ His work extends to supervising and conducting multinational clinical trials focusing on ankylosing spondylitis and rheumatoid arthritis. 🌎📊 His contributions have improved clinical imaging protocols and enhanced the reliability of diagnostic techniques. 🎯 His leadership in medical imaging research and development has made a lasting impact on the field of radiology. 🏅👏

Awards & Honors

Mr. Wen Chang Tseng’s contributions to medical imaging and radiological technology have been widely recognized through numerous accolades. 🏆 His expertise in diagnostic radiology and clinical trial research has earned him prestigious honors, including commendations for excellence in radiologic innovation and clinical research advancements. 🌟 As a leader in medical imaging research, he has been an integral part of groundbreaking Phase II and Phase III multinational studies on ankylosing spondylitis and rheumatoid arthritis. 📈 His pioneering role in clinical trials has led to significant improvements in diagnostic imaging standards, contributing to global advancements in radiology. 🌍 He has also been acknowledged by international research institutions for his commitment to technological advancements in radiologic sciences. 🔬 His dedication and innovation make him a distinguished figure in the field, making him a deserving recipient of the Best Researcher Award. 🏅🎯

Research Focus

Mr. Wen Chang Tseng specializes in diagnostic radiology, medical imaging technology, and clinical trial research. 📡 His work focuses on enhancing imaging techniques for ankylosing spondylitis and rheumatoid arthritis through Phase II and Phase III multinational clinical trials. 🏥 He has played a crucial role in advancing radiologic assessment methods, ensuring precise imaging for improved diagnosis and treatment planning. 🎯 His research integrates medical imaging with electrical engineering, allowing for the development of cutting-edge radiologic technologies. 🖥️⚡ His contributions to clinical trials have led to refined imaging protocols, benefiting global healthcare standards. 🌍 His multidisciplinary expertise in radiology and technology has driven innovation in diagnostic procedures, improving efficiency and accuracy in detecting musculoskeletal disorders. 📊 His research continues to shape the future of medical imaging, contributing to better patient care and medical advancements. 🏆

Publication Top Notes

Assessing the seasonality of occupancy number-associated CO₂ level in a Taiwan hospital

Muritala Suleiman Odidi | Medicine and Health Sciences | Best Researcher Award

Published on 18/06/202418/06/2024 by Research Hypothesis

Muritala Suleiman Odidi | Medicine and Health Sciences | Best Researcher Award

Dr Muritala Suleiman Odidi, Federal University Dutse Jigawa State, Nigeria

Dr. Muritala Suleiman Odidi is a dedicated lecturer at Kogi State University, Anyigba, Nigeria, specializing in gross anatomy, embryology, genetics, biostatistics, and anthropology since June 2018 📚. He uses audio-visual microscopy to enhance histology teaching 🧬. Before academia, he was a Business Development Executive at Emzor Pharmaceutical Industries (2015-2018) and a Senior Medical Sales Representative at Nosak Health Care Limited (2012-2015) 💊. He has attended numerous workshops and conferences globally, contributed to many publications, and holds several administrative roles within his department 🏅. His research focuses on forensic science and anthropometry 🔬.

Publication profile

google scholar

Education

He hold a PhD in Human Anatomy from Ahmadu Bello University, Zaria, Kaduna, conferred on December 16th, 2022 🎓. Prior to this, He completed my MSc in Human Anatomy and Physical Anthropology at Bayero University, Kano, Nigeria, on March 30th, 2016 📚. My academic journey began with a BSc in Human Anatomy from Ahmadu Bello University, Zaria, Kaduna, where I graduated with a second class upper on April 16th, 2009 🎓. This robust educational foundation has equipped me with extensive knowledge and expertise in the field of human anatomy and physical anthropology 🧠.

Experience

Since June 2018, he have been a lecturer, teaching and demonstrating gross anatomy, embryology, genetics, biostatistics, and anthropology to undergraduate medical students. Additionally, he utilize audio-visual microscopy to effectively teach histology 📚. Previously, from March 2015 to June 2018, he worked as a Business Development Executive at Emzor Pharmaceutical Industries Limited in Lagos, Nigeria. In this role, he organized and conducted Continuing Medical Education on the company’s product ranges, brokered business deals with health institutions, and interfaced with Key Opinion Leaders (KOL) 💼. Prior to that, from February 2012 to February 2015, I served as a Senior Medical Sales Representative at Nosak Health Care Limited, where he promoted new products and increased brand awareness during community pharmacist meetings and conferences 🌟.

Awards

He was honored to serve as a Fellow in the Data Science Fellowship Program by the Bureau of Statistics, Kaduna State Government, in collaboration with the Bill and Melinda Gates Foundation (BMGF) from January to July 2021 📊. During this enriching experience, he honed my data science skills and contributed to impactful projects 🎯. Additionally, he received a prestigious prize and Certificate of Honour for meritorious services from the Government of Oyo State of Nigeria, in collaboration with the National Youth Service Corps 🏅. This recognition underscores my dedication and hard work in service to my community and nation 🌟.

Research focus

Based on the provided publication list, M.O. Suleiman’s research focus spans multiple disciplines including forensic science, entomology, anatomy, and toxicology. Their work covers the use of plant-based substances for pest control, the effects of plant extracts on health, and various aspects of human morphology and forensic analysis. This diversity indicates a multidisciplinary approach with significant contributions to both environmental and health sciences.